Indeed, CXCR6 and CXCL16 are upregulated in multiple cancer tissues, including primary and metastatic tissues, and cancer cell lines compared to respective normal ones and their levels increase as tumor malignancy progresses [39,40,41,42,43,44]. The gene discussed is CXCL16; the disease is neoplasm.